Jason O'CONNOR,Joon Bok LEE,Trang LY,Todd VIENNEAU,Yibin ZHENG,Ashutosh ZADE
申请号：
US16586440
公开号：
US20200101225A1
申请日:
2019.09.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A wearable drug delivery device, techniques, and computer-readable media that provide an application that implements a diabetes treatment plan for a user are described. The drug delivery device may include a controller operable to direct operation of the wearable drug delivery device. The controller may provide a selectable activity mode of operation for the user. Operation of the drug delivery device in the activity mode of operation may reduce a likelihood of hypoglycemia during times of increased insulin sensitivity for the user and may reduce a likelihood of hyperglycemia during times of increased insulin requirements for the user. The activity mode of operation may be manually activated by the user or may be activated automatically by the controller. The controller may automatically activate the activity mode of operation based on a detected activity level of the user and/or a detected location of the user.
